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Integration of Kinase and Calcium Signaling at the Level of
Chromatin Underlies Inducible Gene Activation in T Cells
Ruth Brignall,* Pierre Cauchy,† Sarah L. Bevington,† Bethany Gorman,†
Angela O. Pisco,‡ James Bagnall,* Christopher Boddington,* William Rowe,x
Hazel England,* Kevin Rich,*,{,‖ Lorraine Schmidt,* Nigel P. Dyer,# Mark A. Travis,*,{,‖
Sascha Ott,# Dean A. Jackson,* Peter N. Cockerill,† and Pawel Paszek*
TCR signaling pathways cooperate to activate the inducible transcription factors NF-kB, NFAT, and AP-1. In this study, using the
calcium ionophore ionomycin and/or PMA on Jurkat T cells, we show that the gene expression program associated with activation
of TCR signaling is closely related to specific chromatin landscapes. We find that calcium and kinase signaling cooperate to induce
chromatin remodeling at ∼2100 chromatin regions, which demonstrate enriched binding motifs for inducible factors and correlate
with target gene expression. We found that these regions typically function as inducible enhancers. Many of these elements contain
composite NFAT/AP-1 sites, which typically support cooperative binding, thus further reinforcing the need for cooperation
between calcium and kinase signaling in the activation of genes in T cells. In contrast, treatment with PMA or ionomycin alone
induces chromatin remodeling at far fewer regions (∼600 and ∼350, respectively), which mostly represent a subset of those
induced by costimulation. This suggests that the integration of TCR signaling largely occurs at the level of chromatin, which we
propose plays a crucial role in regulating T cell activation. The Journal of Immunology, 2017, 199: 2652–2667.
T
lymphocytes are vital for mounting efficient immune re-
sponses to invading pathogens. When T cells are fully
activated, hundreds of immune response genes are induced
by up to 1000-fold (1). These responses need to be tightly con-
trolled because any inappropriate responses can lead to proin-
flammatory immune disorders. Correctly regulated T cell activation
is underpinned by signaling events that are initiated by the binding
of the cognate Ag to the TCR expressed on the cell surface, and
amplified by the CD28 and other costimulatory receptors that act to
augment TCR signaling (2–4). A simplified view of the TCR/CD28
signaling network is depicted in Fig. 1A to show the major nodes
and targets in this network. However, the signaling machinery that
is actually recruited to the immune synapse is far more complex and
involves considerable crosstalk between the Ca2+ and kinase sig-
naling pathways upstream of the transcription factors (TFs) NFAT,
AP-1, and NF-kB (2, 3, 5). TCR activation triggers signaling from
ZAP-70 to the enzyme phospholipase Cg, which cleaves phos-
phoinisitol phosphate to generate the two critical signaling mol-
ecules inositol triphospate and diacly glycerol. This represents a
major branchpoint upstream of two critical sets of TFs (Fig. 1A).
Inositol triphospate signaling leads to an increase in free intra-
cellular Ca2+, which induces calcineurin-mediated dephosphory-
lation and import of NFAT family TFs into the nucleus (6–8). In
parallel, diacly glycerol activates protein kinase C (PKC)–dependent
induction of IkB kinase (IKK) and the Ras/Raf/MAPK signaling
pathways, leading to the activation of both NF-kB and AP-1, re-
spectively (9, 10). NFAT, NF-kB, and AP-1 cooperate in the acti-
vation of gene expression programs that underpin immune responses
(8, 11, 12). In particular, this involves the upregulation and se-
cretion of IL-2, which supports the clonal expansion of newly
*Faculty of Biology, Medicine and Health, University of Manchester, Manchester
M13 9PT, United Kingdom; †Institute of Biomedical Research, College of Medicine
and Dentistry, University of Birmingham, Birmingham B15 2TT, United Kingdom;
‡Centre for Stem Cells and Regenerative Medicine, King’s College London, London
SE1 9RT, United Kingdom; xDepartment of Chemistry, Loughborough University,
Loughborough LE11 3TU, United Kingdom; {Manchester Collaborative Centre for
Inflammation Research, University of Manchester, Manchester M13 9PT, United
Kingdom; ‖Wellcome Trust Centre for Cell-Matrix Research, University of Man-
chester, Manchester M13 9PT, United Kingdom; and #Warwick Systems Biology
Centre, University of Warwick, Coventry CV4 7AL, United Kingdom
ORCIDs: 0000-0002-0659-0799 (P.C.); 0000-0003-0142-2355 (A.O.P.); 0000-0003-
1735-5855 (J.B.); 0000-0002-8324-614X (H.E.); 0000-0001-7322-496X (K.R.);
0000-0001-6158-0510 (N.P.D.); 0000-0002-0363-0716 (P.P.).
Received for publication December 1, 2016. Accepted for publication August 21,
2017.
This work was supported by Biotechnology and Biological Sciences Research Coun-
cil Grant BB/K003097/1, Wellcome Trust Grant 097820/Z/11/B, and Biotechnology
and Biological Sciences Research Council David Phillips Research Fellowship BB/
I017976/1 (to P.P.). R.B., C.B., and K.R. were funded by Biotechnology and Biolog-
ical Sciences Research Council studentships. P.C., S.L.B., and P.N.C. were supported
by grants from the Biotechnology and Biological Sciences Research Council, Med-
ical Research Council, and Bloodwise. The Wellcome Trust Centre for Cell-Matrix
Research, University of Manchester, is supported by core funding from the Wellcome
Trust (Grant 203128/Z/16/Z). This work was also supported by funding from Euro-
pean Union Seventh Framework Programme (FP7/2012-2017) Grant 305564.
The sequencing data in this article have been submitted to the Gene Expression
Omnibus under accession numbers GSE90718 and GSE100418.
R.B., D.A.J., and P.P. conceived the study; R.B., P.P., and P.N.C. wrote the manu-
script; R.B., A.O.P., and S.L.B. carried out ATAC, RNA-seq, and DNase-seq exper-
iments; P.C., N.P.D., S.O., S.L.B., and P.N.C. performed the ATAC-seq and DNase-
seq data analysis; R.B., W.R., C.B., P.N.C., and N.P.D. performed gene expression
data analysis; B.G., R.B., J.B., and L.S. developed luciferase reporter constructs and
performed related assays; and H.E., K.R., and M.A.T. provided experimental guid-
ance, valuable discussions, and critical feedback.
Address correspondence and reprint requests to Dr. Pawel Paszek or Prof. Peter N.
Cockerill, University of Manchester, AV Hill, Oxford Road, Manchester M13 9PL,
U.K. (P.P.) or University of Birmingham, Birmingham B15 2TT, U.K. (P.N.C.). E-mail
addresses: pawel.paszek@manchester.ac.uk (P.P.) or p.n.cockerill@bham.ac.uk (P.N.C.)
The online version of this article contains supplemental material.
Abbreviations used in this article: ATAC, transposase-accessible chromatin analysis;
ATAC-seq, ATAC using sequencing; DHS, DNase I hypersensitive site; DNase-seq,
DNase sequencing; GSEA, gene set enrichment analysis; IKK, IkB kinase; PKC,
protein kinase C; RNA-seq, RNA sequencing; TEM, T effector memory cell; TF,
transcription factor.
This article is distributed under the terms of the CC BY 4.0 Unported license.
Copyright  2017 The Authors
www.jimmunol.org/cgi/doi/10.4049/jimmunol.1602033
activated T cells, plus many other inducible cytokines such as IL-4,
IL-3, and CSF2 (12–23). Studies of these genes revealed that NFAT
and AP-1 typically bind cooperatively to composite DNA elements
in a specific configuration (11, 21, 24–26).
To better define genomic targets of the TCR signaling network
we recently performed a global analysis of inducible DNase I hy-
persensitive sites (DHSs) in stimulatedmouse T cells (1).We defined
∼1000 highly inducible DHSs, representing potential enhancers or
promoters, which were highly enriched for binding sites for NFAT
and AP-1. One third of these sites contained the composite NFAT/
AP-1 motif depicted in Fig. 1B. Additionally, the binding motif for
NF-kB was detected in 12% of these inducible DHSs.
The activation of gene expression (27, 28) and the establishment
of immunological memory (1, 29–32) in T cells are controlled by
TFs that recruit chromatin modifiers and remodelers to tran-
scriptional enhancers and promoters. Specific promoters and en-
hancers associated with TCR-inducible genes have been shown to
undergo rapid changes in DHSs following stimulation, which is
indicative of regulatory chromatin rearrangements (18, 33, 34). In
particular, NFAT has been extensively associated with alterations
in chromatin structure (35–38) and has been shown to be essential
in inducing DHS formation within the IL2 locus (39). However,
the activity of NFAT is largely dependent on its ability to bind to
DNA cooperatively with AP-1 proteins (15, 21, 24, 25, 40). For
example, T cells expressing engineered NFAT proteins that were
unable to bind AP-1 displayed diminished effector function and
suppression of TCR signaling to inducible genes (40, 41, 42).
NFAT/AP-1 complexes bind cooperatively to composite DNA ele-
ments present in both proximal and distal enhancer regions of many
TCR-inducible genes. Once bound, they typically induce the for-
mation of nucleosome-free DHSs at the regulatory elements that
activate gene expression (15, 24, 36, 37). Overall, these studies
highlight the critical role of enforced cooperation between NFAT
and AP-1 family TFs in maintaining the tight regulation of the
T cell gene expression program. In the absence of this cooperativity,
TCR activation leads to T cell exhaustion (41).
The recent introduction of transposase-accessible chromatin
analysis using sequencing (ATAC-seq) as an alternative to DNase I
for mapping nuclease hypersensitive sites provides another high-
resolution method of investigating the mechanisms involved in
the regulation of gene expression (43). In this study, we employed
RNA and ATAC sequencing to define the gene expression patterns
and chromatin landscapes associated with TCR signaling. To
understand how IKK and MAPK signaling pathways integrate
with Ca2+ signaling pathways within the TCR regulatory network,
we used the calcium ionophore ionomycin and PMA, in combi-
nation or alone, to activate Jurkat T cells, a well-established model
for studying T cell activation (44). We found that full activation of
the core gene expression program associated with T cell activation
was dependent on the synergistic stimulation of both signaling
networks. These T cell activation programs are established by the
rapid remodeling of chromatin upon stimulation, which was found
to be associated with the enrichment of composite NFAT/AP-1
elements. Incomplete stimulation, via PMA or ionomycin alone,
led to specific gene expression profiles that only partially over-
lapped with the patterns induced by full activation. Importantly, a
strong correlation was found between the stimulus-specific gene
expression patterns and the chromatin state.
Materials and Methods
Reagents and cell culture
Human Jurkat T cells (A3 clone from American Type Culture Collection)
were grown in RPMI 1640 media (Sigma-Aldrich) supplemented with 10%
FBS (Life Technologies) and 2 mM L-glutamine (Sigma-Aldrich). Cells
were cultured at concentrations between 2 3 105 and 2 3 106 cells/ml
and incubated at 37˚C and 5% CO2. Cells were stimulated with the calcium
ionophore ionomycin, derived from Streptomyces conglobatus (Sigma-
Aldrich), PMA (Sigma-Aldrich), and TNF-a (Calbiochem).
Development of reporter cell lines
The lentiviral luciferase reporters for IL-2 and NF-kB transcriptional ac-
tivity were generated by inserting a multiple cloning site into a pRE1x
plasmid [a gift from Schibler and colleagues (45)] using EcoRV and Age1
restriction enzymes. The 600-bp proximal promoter of IL-2 was then
cloned into the plasmid using the AscI restriction enzyme to drive the
expression of the luciferase reporter (IL-2–Luc). The reporter for NF-kB
(5kB-Luc), which included the 5x repeat kB consensus sequence was in-
corporated into the sequence using Pac1 and Nhe1 restriction enzymes.
Lentivirus production and transduction were carried out as previously
described (46).
Live-cell luminometry
Cells were plated in 24-well white opaque plates (PerkinElmer) in 1 ml of
media, prior to incubation with luciferin (0.5 mM; Biosynth, Staad,
Switzerland) for at least 4 h before assaying. Live-cell measurements were
then collected using a FLUOstar Omega microplate reader (BMG Labtech)
with an attached incubator that maintained cells at 37˚C and 5% CO2.
Readings were taken from individual wells every 10 min with an 18-s
integration time for up to 48 h. Results are shown as mean fold induction
relative to an untreated control 6 SD of at least three independent ex-
periments. For statistical analysis, the maximum luminescent intensity for
each condition was generated before calculating a p value using an un-
paired t test.
Detection of IL-2 by ELISA
Jurkat T cells were plated at 5 3 105 in 2 ml of media before being in-
cubated with the appropriate stimuli for 24–48 h. Supernatant was cleared
of cells and debris by centrifugation at 300 3 g for 5 min. The supernatant
was then aliquoted and stored at 220˚C for future use. Measurement of
secreted protein levels was performed using specific human IL-2 ELISA
kits (R&D Systems) following the manufacturer’s instructions. Absor-
bance was measured at 370 nm using a FLUOstar multimode microplate
reader. Statistical analysis was performed with a nonparametric one-way
ANOVA.
Western blotting
Cells were lysed with 200 ml of lysis buffer (50 mM Tris-HCl [pH 7.4], 1%
Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl,
2 mM EDTA, 50 mM NaF). Samples (18 ml) were then loaded onto gels
alongside 8 ml of protein ladder. The proteins were then transferred to
nitrocellulose membranes before incubation in blocking buffer (5% [w/v]
skimmed milk powder in TBST) for 1 h at room temperature. The blots
were then washed in TBST and incubated overnight with anti-NFATc2
(NFAT1) (BD Transduction Laboratories) or anti–phospho-p65 (S536)
(Cell Signaling Technology) primary Abs (BD Transduction Laboratories)
at 1:5000 and 1:1000 dilution, respectively, in 5% (w/v) BSA in TBST.
Blots were washed in TBST and then incubated for a further hour with a
1:2000 dilution of HRP-conjugated anti-IgG (Cell Signaling Technology).
After a final TBST wash to remove any unbound Ab, a 1:1 ratio mix of
ECL Advance Western blotting detection kit reagents was then applied to
the membrane and left for 1 min, before visualizing HRP-conjugated
proteins using a Bio-Rad Gel Doc XRS+ system. Membranes were then
restained with an anti–a-tubulin primary Ab (Cell Signaling Technology),
and the detection process was repeated to produce a loading control.
RNA isolation and RNA sequencing analysis
Wild-type Jurkat T cells were plated at a density of 53 106 cells/ml in 2 ml
of media. Total RNA was extracted from cells at appropriate time points
after stimulation using the Roche High Pure RNA isolation kit according to
the manufacturer’s instructions. The RNA was then quantified using a
Nanodrop ND-1000 spectrophotometer (Thermo Fisher Scientific). RNA-
seq was then carried out using the TruSeq Stranded mRNA assay (Illu-
mina). In brief, this involved purifying polyadenylated mRNA from 0.1 to
4 mg of total RNA, using poly-T, oligonucleotide-attached magnetic beads.
The mRNAwas then fragmented by divalent cations, before being reverse
transcribed into first-strand cDNA using random primers. DNA polymerase
I and RNase H were then used to synthesize the second-strand cDNA.
Adapters were then ligated to the cDNA fragments, and the products were
purified and enriched by PCR to generate the final cDNA library. Samples
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were then paired-end sequenced using an Illumina HiSeq 2500 instrument
(100 plus 100 cycles, plus indices). We sequenced an average of 22 million
reads per library and aligned them to the human reference genome
(hs37d5) using TopHat (release 2.1.0) (47) with default parameters. mRNA
expression levels were calculated per gene using htseq-count (release
0.6.0) (48) with option “-s reverse -i gene_id -m intersection-nonempty”
against release 19 of the comprehensive genome annotation from GENCODE.
The counts were normalized to adjust for the difference in total number of
counts associated with each sample and pooled across triplicates. The anal-
ysis focused on genes that were differentially expressed by a fold change of 2
or 5 in comparison with the unstimulated control. The average normalized
RNA expression values determined by RNA-seq for annotated regions of the
genome are presented in Supplemental Table I together with the fold in-
duction values determined after stimulation.
Public access to sequence data
All high-throughput sequencing data generated by this study are available at
Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE90718) accession number GSE90718.
RNA analysis by NanoString
RNAwas extracted from Jurkat T cells as outlined above, either untreated or
stimulated with PMA/ionomycin for 3 h. RNAwas assayed using a custom-
made human nCounter kit (NanoString Technologies), which contained a
CodeSet of capture and reporter probes from 49 genes, identified by the
RNA-seq analyses, including cytokines, chemokines, TFs, and surface markers
associated with T cell activation (NanoString data included as Supplemental
Table II). One hundred twenty-five nanograms of RNA was used in each
CodeSet hybridization reaction. NanoString data were analyzed using nSolver
analysis software v1.1 (NanoString Technologies). The results were normal-
ized to the level of housekeeping genes and positive controls included in the
CodeSet, whereas negative controls were subtracted from the normalized data.
The data were then presented as the average of three biological replicates and
plotted against data obtained via RNA-seq.
RNA-seq correlations to public data
To directly compare our RNA-seq data with public data, raw fastq data from
human Teffector memory cells (TEMs) with and without 150-min CD3 plus
CD28 stimulation (49) were retrieved from Gene Expression Omnibus
series accession numbers GSM2370626 (resting) and GSM2370628 (with
150-min CD3 plus CD28), converted from SRA to fastq with the SRA
Toolkit fastq-dump using the split-files option to obtain paired-end fastq
files. Reads were subsequently aligned to the hs37d5 release of the human
genome using TopHat, as in this study. To obtain comparable gene ex-
pression levels, normalized fragments per kilobase of transcript per million
mapped reads counts, using bam files from TEMs with and without
150-min CD3 plus CD28 stimulation together with those from our study,
were obtained using cuffnorm (50). For scatter plots, the genes.fpkm_table
was read and log2 transformed in R, with counts plotted with the plot
function. Pearson correlation coefficients were obtained using the cor func-
tion. TEM 2-fold–inducible genes were defined as those showing a fold
change.13 log2 with CD3 plus CD28 stimulation. For gene set enrichment
analysis (GSEA), the GSEA package (51) was employed using a GSEA-
readable version of the genes.fpkm_table as the expression dataset, the list of
TEM 2-fold–inducible genes as the gene set group file, as well as a pheno-
type file describing the conditions used (Jurkat, Jurkat plus PMA/ionomycin).
Parameters used were classic enrichment, average of probes, official gene
symbol chip dataset, and gene-set permutation.
ATAC-seq
To profile open chromatin, we modified the previously published ATAC-seq
protocol (43): to isolate the Jurkat T cell nuclei, 50,000 cells were pelleted
by centrifuging at 5003 g and 4˚C for 10 min. Cells were then washed with
50 ml of cold PBS before being pelleted again as outlined above. Pellets
were then resuspended in 500 ml of Nuclei EZ lysis buffer (Sigma-Aldrich)
and placed on ice for 10 min. Finally, cells were pelleted by centrifugation
at 500 3 g and 4˚C for 10 min before the supernatant was discarded. The
isolated nuclei were then resuspended in a 50-ml reaction buffer containing
5 ml of Tn5 transposase and 25 ml of TD buffer (Nextera sample prepa-
ration kit from Illumina) and incubated at 37˚C for 1 h. The DNAwas then
purified using DNA Clean & Concentrator (Zymo Research) and eluted
into 23 ml of elution buffer. For library amplification, 20 ml of DNA was
combined with 5 ml of indexing primers (Nextera sample preparation kit),
15 ml of Nextera PCR master mix, and 5 ml of Nextera PCR primer
cocktail. DNA was then amplified for 15 cycles to enrich the tagmented
DNA fragments. A PCR clean-up was then performed using AMPure XP
beads (Beckman Coulter), and the small fragments were then resuspended
in 32.5 ml of resuspension buffer (provided in the Nextera kit). DNA was
quantified using a Qubit fluorometer (Life Technologies), and library sizes
were then determined using TapeStation (Agilent Technologies). Sequencing
was performed using a HiSeq 2500 to obtain an average of 60 million reads
per sample.
Alignment of ATAC-seq data
Trimmomatic (release 0.33) (52) was used in paired end mode to trim the
adaptor sequence and separate sequences where both read ends were
retained from sequences where only a single read was retained. Reads that
aligned to the mitochondrial genome were removed in Bowtie 2 (release
2.2.5) (53). Bowtie 2 was then used first to align the trimmed paired-end
data and then the single-ended read data to the hs37d5 reference genome.
ATAC-seq peaks were identified using CisGenome (54) in one-sample
mode based on reads from combined PMA and ionomycin treatment
with options “-w 100 -s 25 -c 15 -g 0 -l 0 -br 0 -ssf 0.” Peak sizes were
calculated by determining the number of fragment ends that were located
within each peak for each of the samples separately. ATAC data are
available at Gene Expression Omnibus (accession no. GSE90718) and are
summarized in Supplemental Table III.
Peak detection and filtering; coverage track generation
Replicate bam files were first merged using samtools merge (55). Peak
detection and coverage track generation were subsequently performed via
MACS (56) on merged replicates, using –keep-dup = auto -g hs -w -S.
Peak and summit filtering was performed as previously described (57).
Regions intersecting with regions previously published as blacklisted (58)
as well as with simple repeats were excluded using bedtools intersect with
-v as a parameter (59). For screenshots, coverage track files were uploaded
to the University of California Santa Cruz Genome Browser (60).
Two-way fold change analysis
Two-way combinations of filtered summit files were merged using the fol-
lowing bash command: cat , summits_A . .bed , summits_B . .bed |
bedtools sort -i - | bedtools merge -i - -d 200. Tag counts for each experiment
were retrieved for merged summits using the annotatePeaks function of the
Homer package (61) using -hist 10 -ghist -wig as parameters. Tag counts
were normalized via center scaling and subsequently sorted on log2 treatment/
control fold change. Heat map images were obtained using Java TreeView
(62). Annotation to the closest gene was performed using bedtools closest
using the hg19 refFlat annotation, with -t first as a parameter.
Motif discovery and heat maps
Motif discovery was performed with the findMotifsGenome function of
Homer on regions showing enrichment$2 log2-fold change versus control,
using default parameters. For isolation of the NFAT/AP-1 motif, motif
discovery was performed on PMA plus ionomycin regions $2 log2-fold
change versus control, using -len 16 as a parameter for findMotifsGenome.
For motif heat maps, mapping of motifs was performed using the annotate-
Peaks function of Homer, using -hist 10 -ghist -size 2000 -m as parameters.
Heat map images were obtained using Java TreeView. For motif discovery
for the NFAT/AP-1 motif in 23 inducible human T-blast peaks, motif dis-
covery was performed using Homer findMotifsGenome using -len 16 as a
parameter to first look for 16-bp motifs. Motif optimization was then per-
formed using Homer findMotifsGenome -len 20 -opt,16 bp motif., as the
original 16-bp motif isolated was offset.
Digital genomic footprinting profiles
To assess motif occupancy by TFs, average ATAC insertion profiles around
motifs identified from ATAC-seq peaks were retrieved using the dnase_
average_profiles function of the Wellington package (63), using -A -n as
parameters, -n performing normalization, and -A causing shifting of the
reference genome coordinates by 24 and +5 bp, resulting in a shift of +4
and 25 bp as originally described for ATAC-seq footprinting (43).
Venn diagrams
For ATAC-seq, Venn diagrams were obtained using pybedtools (64). For
RNA-seq, BioVenn was used (65).
ATAC correlations to public histone H3K27Ac chromatin
immunoprecipitation sequencing data from primary T cells
Jurkat ATAC data were compared with published histone H3K27Ac
chromatin immunoprecipitation sequencing data from stimulated human
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T cells. Raw H3K27Ac data from resting CD4+CD252 and PMA/ionomycin-
stimulated CD4+CD252IL-172 PBMC Th cells from the epigenome
roadmap (66) were retrieved from Gene Expression Omnibus accession
numbers GSM997239 and GSM772905, respectively. Reads were aligned
to the hg19 genome assembly via Bowtie 2 to the bam format using the
–very-sensitive-local parameter. Peak detection and coverage track genera-
tion was performed using macs14 using the –keep-dup = auto, g = hs, -w -S
switches. A fold change analysis was carried out to determine 23 PMA/
ionomycin enriched peaks versus resting. To map these peaks back onto the
Jurkat PMA/ionomycin versus resting fold change, a left outer join was
performed using coordinates sorted by increasing Jurkat PMA/ionomycin
versus resting fold change and 23 PMA/ionomycin inducible H3K27ac
peaks, using bedtools intersect with -loj as a parameter. Heat map images
were obtained using Java TreeView.
DNase I hypersensitive site analysis in human T cells
DNase sequencing (DNase-seq) was performed on previously described
DNA samples purified from DNase I–digested chromatin derived from
actively dividing human peripheral blood T cells (67). This material was
generated from PBMCs that had been first stimulated with PHA for 2 d to
generate T lymphoblasts, and then cultured for several cell cycles in the
presence of recombinant human IL-2 as previously described (67). Cells
were then either left untreated or stimulated for 5 h with 20 ng/ml PMA
plus 2 mM calcium ionophore A23187 before performing DNase I di-
gestions as previously described (67). DNase-seq libraries were prepared
from ∼100- to 150-bp fragments as previously described (1).
DNase-seq data processing
Using the Galaxy interface (68), single-ended DNAse-seq reads were
aligned to the hg19 genome assembly via Bowtie 2 to the bam format using
the –very-sensitive-local parameter. Peak detection and coverage track
generation was performed using macs2 using the –keep-dup = auto, g = hs,
-w -S switches. Fold change analysis was carried out to identify 2-fold
PMA/ionomycin-enriched peaks relative to untreated controls. Raw
DNase-seq data were deposited on Gene Expression Omnibus under ac-
cession GSE100418.
Luciferase reporter gene assays of DHSs
Inducible DHSs were tested for inducible enhancer function using the
previously described firefly luciferase reporter gene plasmid pTK229 (69).
DNA fragments spanning each DHS were amplified by PCR from Jurkat
T cell genomic DNA using primers with adapter sequences designed for
cloning into the BamHI and XhoI sites upstream of the herpes simplex
thymidine kinase promoter in pTK229. The primers had the following
sequences, with the adapter portion shown in lowercase: GEM upstream
DHS, 59-taagggatccCGCTTGTCAGGGCATCATTTTCT-39 and 59-cttac-
tcgagAATGGAACTGGTGGCCTGCC-39; GEM intron DHS, 59-taaggg-
atccACACTGGCCCTATTTCTCCCT-39 and 59-cttactcgagCCACAGCTT-
CAGTCTGAGCGT-39; DUSP5, 59-taagggatccATTGAAGGCTGCCGTG-
AGTG-39 and 59-cttactcgagTTCTGGGTGGGGTGTTGGGT-39; ZBTB16,
59-taagggatccTGCCTCCTCGACAGCTCAGA-39 and 59-cttactcgagACT-
TCCCACCATACCCAGTTCT-39. As an additional control we employed a
previously described plasmid that includes the IL3 237 kb enhancer cloned
as an XbaI fragment (X37) into pTK229 (16). Plasmids were assayed in
Jurkat T cells by transient transfection assay using the dual luciferase
method, together with the Renilla firefly control plasmid pRL-TK, as pre-
viously described (16). Transfected cells were cultured for 24 h and then
stimulated for 8 h with 20 ng/ml PMA and/or 2 mM calcium ionophore
A23187, before harvesting cell lysates for assay using a Dual-Luciferase kit
(Promega).
Results
Uncoupling of the kinase and Ca2+ signaling networks using
stimulation via just PMA or ionomycin alone
To investigate the gene regulation networks downstream of TCR
signaling (Fig. 1A) we used either PMA or the Ca2+ ionophore
ionomycin alone to stimulate just the PKC- or calcineurin-mediated
pathways in Jurkat T cells. In agreement with previous analyses
(70–72), stimulation with PMA alone resulted in NF-kB pathway
activation (as visualized by stimuli-induced p65 phosphorylation)
whereas stimulation with ionomycin alone led to NFAT activation
(as exhibited by NFATc2 dephosphorylation, resulting in a faster
migrating protein) (Fig. 1C, 1D). PMA stimulation in the absence of
calcineurin activity is also known to be a strong inducer of AP-1 in
Jurkat cells (18).
To investigate transcriptional responses to PMA and ionomycin,
we employed Jurkat T cells transfected with luciferase reporter
gene lentiviruses, driven by either the full-length NFAT/AP-1–
dependent IL-2 promoter (IL-2–Luc) or an array of five NF-kB sites
(5kB-Luc). Combined PMA and ionomycin treatment resulted in
activation of both NF-kB and NFAT/AP-1–dependent transcription,
peaking after ∼8–10 h (Fig. 1E, 1F). In Jurkat cells this treatment
also led to de novo production of secreted IL-2 protein (Fig. 1G), a
major growth factor involved in clonal expansion and a well-
established marker of T cell activation (13, 14). PMA or ionomycin
treatment alone did not elicit an IL-2 promoter response, confirming
that Ca2+ and PKC costimulation is required for robust IL-2 pro-
moter activation in T cells. These results mirror those seen previ-
ously for the NFAT/AP-1–dependent IL-3 and GM-CSF (CSF2)
genes in Jurkat T cells (18). PMA alone did, however, induce a
modest NF-kB–dependent response (Fig. 1E).
Distinct gene expression patterns are associated with
ionomycin and/or PMA stimulation
To define specific gene targets downstream of pathways induced
by PMA and/or ionomycin, and to investigate correlations between
chomatin structure changes and inducible gene expression, we
characterized global mRNA profiles and chromatin accesibility
patterns using RNA and ATAC sequencing. We identified 1648
genes whose expression was increased by $2-fold by at least one
treatment in comparison with untreated cells (Fig. 2A). There were
1159 genes activated 2-fold by the combined treatment, and, of
these, 455 were activated by $5-fold (Fig. 2A, 2B, Supplemental
Table I). Overall, genes upregulated upon ionomycin or PMA
treatment alone showed little overlap. The combined treatment
resulted in upregulation of many genes that were activated by a
single stimulus, plus numerous genes not seen with either treat-
ment alone.
Hierarchical clustering confirmed that most of the 1648 upreg-
ulated genes were activated by the combined PMA and ionomycin
stimulation (groups I, XI, XVI, and XVII), and out of 1159 genes
activated 2-fold, 52% were uniquely regulated by the combined
treatment (Fig. 2C) (see group XVII for uniquely regulated genes).
This gene set includes key inflammatory cytokines and growth
factors such as TNF, IL2, IL3, and CSF2 (13, 14, 37) and other
immune mediators such as CRTAM, SLAMF1, MMP10, and GEM
(Fig. 3A, Supplemental Table I). The expression patterns of these
genes are consistent with the requirement for synergistic activation
via kinase and Ca2+ signaling.
A large number of genes were also activated by PMA treatment
alone (group VII), with 811 genes upregulated by 2-fold and 203 of
these by 5-fold (Fig. 2A, 2B, Supplemental Table I). Most of these
were a subset of the PMA/ionomycin-inducible genes (total of 393,
group XI) (Fig. 2C). These included DUSP5, which was induced by
PMA alone but was activated to a greater extent by costimulation
with ionomycin (Fig. 3A). However, it also included inducible genes
such as the TF gene EGR1, a known regulator of the IL-2 pro-
moter (73), which was activated by PMA but partially suppressed by
costimulation with ionomycin (Fig. 3A). As PMA alone induced
a similar subset of TFs to proinflammatory cytokines, including
NF-kB and AP-1, the PMA-inducible genes were compared with
genes that were induced by TNF (Table I). Out of a total of 36 genes
that were induced at least 5-fold by TNF, we identified 27 that were
also induced at least 2-fold by PMA, with 24 of these being induced
by at least 5-fold. Many of these genes function as immune regu-
lators, including two members of the NF-kB family of TFs (NFKB2
and RELB), as well as the NF-kB inhibitor NFKBIA (Table I).
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A group of 318 genes was induced by at least 2-fold by the Ca2+
signaling pathway via ionomycin alone (Fig. 2A, Supplemental
Table I). Of these, just 42 genes were upregulated by $5-fold,
which was far fewer than the number of genes induced by PMA
alone (Fig. 2B). These included the TF PLZF encoded by ZBTB16
(Fig. 3A). This observation is consistent with previous observa-
tions that NFAT activation on its own is more strongly associated
with chromatin remodeling than with transcriptional activation
(15). These results suggest that in vitro activation of the full
complement of TCR-responsive genes is dependent on both PMA
and ionomycin and amounts to more than just the sum of both.
To confirm the validity of the RNA-seq data, we compared a
subset of the above datawith values obtained byNanostring analyses.
For both untreated and PMA/ionomycin-stimulated cells, the
Nanostring values correlated well with the RNA-seq values (Fig. 2D,
Supplemental Table II).
To confirm that Jurkat T cells represented a valid model for
studying the PMA/ionomycin induciblity of genes in T lineage
cells, we compared the above data obtained from stimulated Jurkat
cells with published data obtained from primary human TEMs
stimulated using CD3 and CD28 Abs (Fig. 2E) (49). This analysis
demonstrated that there was a good correlation between the two
data sets. These conclusions were further supported by GSEA
comparing the two data sets (Fig. 2F).
Stimulus-specific gene expression patterns correlate with
chromatin landscapes
To link changes in chromatin structure with inducible gene ex-
pression profiles, we analyzed ATAC-seq profiles that were collected
simultaneously with the RNA-seq analyses. ATAC-seq is a surrogate
for DHS analysis and it is similarly used to identify accessible re-
gions of DNA. Accessible DNA regions are free from nucleosomes
within chromatin, and they are typically occupied by TFs in place of
histones (43). Typical ATAC-seq profiles are shown in Fig. 3B,
where it can be seen that additional ATAC peaks are acquired in
inducible loci in patterns that mirror the patterns of mRNA induc-
tion seen in Fig. 3A. For CRTAM, SLAMF1, MMP10, and GEM
there are prominent peaks that are induced via the combined PMA
FIGURE 1. PMA and ionomycin treatment decouple the IKK/MAPK and calcium signaling networks in Jurkat T cells. (A) Schematic representation
of TCR signaling network. (B) Composite consensus binding motif for cooperative binding of NFAT and AP-1 (1). (C and D) Immunoblotting analyses of
NF-kB phospho-p65 (C) and NFATc2 protein expression levels in Jurkat T cells. Cells stimulated with PMA (20 ng/ml), ionomycin (1 mg/ml), or PMA/
ionomycin (20 ng/ml PMA/1 mg/ml ionomycin) for 15 and 60 min, respectively. (E and F) Time series live-cell luminometry analysis of Jurkat T cells
expressing reporters of NF-kB–dependent transcriptional activity (E) or IL-2 promoter activity (F) following treatment with PMA, ionomycin, or PMA/
ionomycin for 48 h (in triplicates, with error bars indicating SDs). (G) Concentration of IL-2, measured by ELISA, secreted by Jurkat T cells treated with
PMA/ionomycin (20 ng/ml PMA/1 mg/ml ionomycin), ionomycin (1 mg/ml), or PMA (20 ng/ml). Means (6SDs) of triplicate experiment is shown in red.
ND, not detected.
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and ionomycin treatment, but not in response to either agent
alone. This pattern is consistent with cooperation between NFAT
and AP-1. For the ionomycin-inducible ZBTB16 gene there is an
ionomycin-induced ATAC peak. For the PMA-inducible DUSP5
gene there are two PMA-inducible ATAC peaks, one of which is
further induced upon addition of ionomycin, in parallel with
DUSP5 mRNA. In contrast, the PMA-inducible EGR1 gene also
exhibits a PMA-induced ATAC peak, but in this case the peak is
FIGURE 2. Distinct gene expression patterns are associated with PMA and/or ionomycin stimulation. (A and B) Venn diagrams showing the overlaps
between PMA-, ionomycin-, and PMA/ionomycin-regulated genes in Jurkat cells for genes that are upregulated by at least 2-fold (A) or 5-fold (B) by each
condition relative to untreated cells. (C) Hierarchical clustering analysis of PMA, ionomycin, or PMA/ionomycin-regulated genes from (A). Data are
presented as a heat map showing normalized read counts across rows. Different clusters are depicted with roman numerals. (D) Comparison of mRNA
levels determined by RNA-seq of untreated and PMA/ionomycin-stimulated Jurkat T cells, using the above data, compared with RNA analyses of a subset
of genes by Nanostring (using the same treatment protocol). (E) Comparison of mRNA levels determined by RNA-seq of stimulated Jurkat T cells, using the
above data, compared with stimulated TEM cells using published data (49). The Jurkat T cells were stimulated for 3 h with PMA and ionomycin as above,
whereas TEMs were stimulated for 150 min with CD3 and CD28 Abs (49). (F) GSEAwas performed using genes that are 2-fold induced in TEMs by CD3
and CD28 Abs, compared with genes sorted according to the level of induction in PMA/ionomycin-stimulated Jurkat cells. All genome-wide RNA-seq data
are available in Supplemental Table I, which lists the averages of three independent RNA-seq values, and the fold change in response to specific stimuli.
Nanostring data for mRNA expression are available in Supplemental Table II.
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suppressed by the addition of ionomycin, in parallel with sup-
pression of mRNA expression.
To determine whether the above ATAC data were representative
of rapidly proliferating primary human T cells, we performed a
DNase I sequencing analysis of DHSs present in bulk human T
lymphoblastoid cells, generated by first stimulating human pe-
ripheral blood T cells with PHA and then expanding them by
culture in the presence of IL-2 (67). This confirmed that most
of the ATAC peaks induced by PMA/ionomycin in Jurkat T
cells were also induced by the same stimuli in nontransformed
proliferating human T cells (Fig. 3B). Interestingly, a cluster of
metallopeptidase genes encompassed an array of ATAC peaks
spanning MMP10 that were induced in Jurkat T cells but not in
primary human T cells.
FIGURE 3. Representative gene expression patterns and corresponding chromatin changes. (A) Bar graphs of individual gene expression patterns de-
termined by RNA-seq and measured in fragments per kilobase of transcript per million mapped reads. Error bars indicate SDs based on triplicates. Shown
are representative patterns observed in the data. (B) University of California Santa Cruz Genome Browser shots of the ATAC-seq patterns present in Jurkat
T cells for different gene loci following treatment with 20 ng/ml PMA, 1 mg/ml ionomycin, or PMA and ionomycin (20 ng/ml PMA/1 mg/ml ionomycin)
for 3 h, and DNase-seq profiles of human T lymphoblastoid cells before and after treatment with 20 ng/ml PMA plus 2 mM calcium ionophore A23187 for 5 h.
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An analysis of the sequences of four of the inducible ATAC
peaks (marked by asterisks in Fig. 3B) showed that two PMA/
ionomycin-inducible peaks in the GEM locus contained both
NFAT and AP-1 motifs, an ionomycin-induced ATAC peak in
ZBTB16 contained four NFAT motifs, whereas a PMA-induced
peak near EGR1 contained two AP-1 motifs and one NFAT motif,
which can account for the observed responses of these elements
(Fig. 4A). These four regions were also tested for enhancer activity
in transient transfection assays of luciferase reporter genes in Jurkat
T cells, using the PMA/ionomycin-inducible human 237 kb IL-3
enhancer (16) as a control (Fig. 4B). These analyses demonstrated
that each region functions as an inducible enhancer dependent on
both PMA and ionomycin. These findings revealed that enhancer
activity still required both calcium and kinase signaling, even in
instances when the corresponding ATAC peak was induced by ei-
ther PMA or ionomycin alone.
Global analysis of ATAC and mRNA profiles
As was seen above at the mRNA level, stimulation with PMA
or ionomycin alone induced far fewer specific ATAC peaks than
were induced by PMA plus ionomycin (Fig. 5). We identified
2795 ATAC peaks that were induced in Jurkat cells by PMA and
ionomycin at least 2-fold, which were associated with 2158 genes.
The profiles of all of the 19,763 peaks identified in untreated or
PMA/ionomycin-stimulated Jurkat cells (Supplemental Table III)
are depicted in Fig. 5B, which shows the ATAC peak profiles
centered within 2-kb regions and ranked in order of increasing
inducibility. PMA induced 732 peaks 2-fold, and these were as-
sociated with 685 genes, whereas ionomycin induced 445 peaks
2-fold, which were associated with 412 genes. The vast majority
of the genes with peaks induced by PMA or ionomycin alone also
have peaks induced by the combined treatment (Fig. 5A). Our
results suggest that in vitro activation of TCR-responsive en-
hancers requires treatment with both PMA and ionomycin, re-
sulting in the activation of regulatory elements not induced by either
alone. The PMA/ionomycin-inducible peaks represented 14% of the
total number of ATAC peaks detected in either stimulated or non-
stimulated Jurkat cells.
To correlate the ATAC data with the mRNA data, we depicted the
inducible responses of the genes nearest to the ATAC peaks as heat
maps, showing the relative fold changes in expression in response
to the three different treatments (Fig. 5B–D). These analyses rein-
forced the view that the combination of PMA and ionomycin was
a much stonger inducing agent than ionomycin alone, whereas
PMA alone was sufficient to activate a larger subset of genes than
ionomycin alone.
To track the responses of individual genes, we directly compared
the individual inducible responses to the single and combined
stimuli for each of the 455 genes where mRNAwas induced 5-fold
(Fig. 6A), and for each of the 2795 ATAC peaks that were induced
2-fold (Fig. 6B) by the combined stimulation with PMA and
ionomycin. The mRNA responses to PMA revealed a trend for the
whole population of 455 inducible genes to show partial responses
to PMA alone, but most of these had much stronger responses to
the combined treatment. In contrast, the pattern of mRNA responses
to ionomycin more closely resembled that seen for unstimulated
cells. The ATAC data showed a similar trend whereby PMA, but not
ionomycin, induced partial responses at many chromatin regions.
The fold-change analyses in Fig. 6B and 6C also showed that many
of the ATAC peaks were partially induced by PMA alone, and to a
greater extent than by ionomycin alone. The magnitudes of the
changes induced in ATAC peaks by ionomycin were mostly within
the margins of error, confirming that ionomycin alone is largely
ineffective at inducing either chromatin accessibility or mRNA
expression.
Enriched TF binding motifs reflect T cell activation markers
To gain insights as to how simultaneous stimulation with PMA and
ionomycin could result in activation of specific elements not in-
duced by either treatment alone, we hypothesized that this might be
due to these elements requiring binding of the full complement of
TCR-induced TFs at the same time (i.e., AP-1, NFAT, and NF-kB),
including the composite motif for AP-1 and NFAT (Fig. 1B). To
identify TFs involved in treatment-specific chromatin landscapes,
we used HOMER to perform an unbiased search for enriched
TF binding motifs within accessible regions of chromatin (66)
(Fig. 7A). Motifs identified in this way were then mapped over the
coordinates of the DHS profiles depicted above in Figs. 5 and 7B.
These analyses revealed the motif signatures of the NFAT, AP-1,
EGR, and NF-kB families of TCR-inducible TFs in the PMA/
ionomycin-inducible ATAC peaks (Fig. 7). The NFAT motifs were
identified in this study as part of the previously described composite
NFAT/AP-1 motif, which is known to integrate Ca2+ and kinase
signaling pathways in T cells (11, 21, 24–26). The NFAT, AP-1, and
NF-kB motifs were all preferentially enriched in the inducible
ATAC peaks (Fig. 7B).
HOMER analysis of the PMA-inducible ATAC peaks revealed
motif signatures for the kinase-inducible TF AP-1 (Fig. 7A); im-
portantly, however, no NFAT motifs were seen in the DHS profiles
of the PMA-inducible ATAC peaks (Fig. 7B). This reflects the
conclusions above that PMA alone does indeed induce a subset of
genes in the absence of Ca2+ signaling.
Curiously, HOMER analysis of the ionomycin-inducible ATAC
peaks revealed motif signatures for both AP-1 and NFAT. Hence,
AP-1 motifs are enriched in DHSs induced by Ca2+ signaling even
in the absence of AP-1. We interpreted this as meaning that
NFAT motifs are rarely found in inducible DHSs in T cells in this
Table I. Genes regulated by the PMA and TNF treatment
TNF Fold Change PMA Fold Change
MIR146A 40.5 46.1
WNT10A 30.9 11.5
CHRNA6 25.1 3.0
CCL1 17.3 11.9
BIRC3 16.2 14.9
BCL3 16.1 15.7
RELB 14.7 16.5
IL-4I1 13.9 11.7
NFKBIA 13.1 5.8
LTB 11.9 46.1
KREMEN2 8.2 4.2
NFKB2 8.0 6.8
PGLYRP4 7.7 17.2
RGS16 7.3 26.8
GATA3-AS1 7.3 16.4
EPHA2 6.8 6.7
IER3 6.5 92.8
TTC40 6.2 4.2
TNFSF10 5.8 6.4
NINJ1 5.7 7.7
TNFAIP3 5.7 7.3
SGK1 5.6 23.6
FCGBP 5.6 3.9
CYTH4 5.6 8.2
PRR9 5.4 21.7
TNFRSF18 5.3 25.6
TRAF4 5.1 5.9
PGLYRP3 5.1 6.5
Subset of 28 of the 36 genes induced at least 5-fold by TNF, which are also
induced at least 2-fold by PMA, showing the fold induction in Jurkat T cells com-
pared with nonstimulated cells. This list includes 24 genes induced at least 5-fold by
PMA. Jurkat cells were stimulated with 30 ng/ml TNF for 3 h.
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absence of its usual partner AP-1, and that NFAT rarely functions
to activate gene expression on its own. However, in some cases it
is clear that NFAT is sufficient to induce DHSs in the absence of
AP-1, presumably at sites that encompass a sufficient number of
high-affinity motifs, for example the DHS defined above in the
ZBTB16 locus (Fig. 4A).
The inducible DHSs were also enriched to varying degrees in
RUNX and ETS motifs, which are sometimes observed as com-
posite ETS/RUNX motifs (1, 60) and are known to function widely
to regulate gene expression in T cells and at other stages of blood
cell development (1, 74, 75). Inducible DHSs also contain motifs
for TCF/LEF family TFs (76). However, these constitutive TFs
were more enriched in PMA- or ionomycin-specific peaks than in
PMA/ionomycin-specific sites, suggesting that the latter are truly
inducible sites. Overall, our results suggest that the activation of
TCR-inducible enhancers requires binding of both AP-1 and
NFAT, either to distinct motifs or as a composite motif, as well as
NF-kB binding.
To find evidence directly linking inducible chromatin acces-
sibility with TF activity, we used the Wellington algorithm (63)
to perform a digital footprinting analysis of occupied TF binding
motifs. We centered the average ATAC transposase insertion
profiles at genomic coordinates of specific motifs identified in
PMA/ionomycin-inducible peaks (Figs. 7, 8). This produced
strong evidence that AP-1, NFAT, and NFAT/AP-1 motifs were
indeed occupied within the ATAC peaks in cells stimulated
with PMA and ionomycin. These data also suggested that stable
AP-1 and NFAT binding, as well as chromatin opening, are
highly cooperative processes relying on both kinase and cal-
cium signaling, because much less evidence of occupancy was
FIGURE 4. Analyses of sequences found at inducible ATAC peaks. (A) Inducible NFAT, AP-1, and or EGR binding motifs are present in the sequences
corresponding to stimulus-specific ATAC-seq peaks. Shown are the analyses of inducible ATAC peaks from the PMA/ionomycin-inducible GEM locus, the
ionomycin-inducible ZBTB16 locus, and the PMA-inducible DUSP5 locus (corresponding peaks marked by asterisks in Fig. 3B). (B) Luciferase reporter
gene analysis of inducible enhancer function for the above sequences from ZBT16, DUSP5, and GEM genes, plus the inducible human 237 kb IL-3 gene
enhancer (16) used in this study as a positive control.
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detected after stimulation with either PMA or ionophore alone
(Fig. 8).
Jurkat T cells and primary human T cells share a common set
of inducible DNA elements
A global analysis of the PMA/ionomycin-inducible DHSs
identified in human T blast cells revealed 8171 DHSs that were
induced 2-fold relative to untreated cells (Fig. 9A). These in-
ducible DHSs had a similar TF motif composition to the above
PMA/ionomycin-inducible Jurkat ATAC peaks (Fig. 7A), and to
the PMA/ionomycin-inducible DHSs present in mouse T blast
cells (1) (Fig. 9C). We found that 1051 of these DNA elements
were inducible in both Jurkat T cells and in primary T cells
(Fig. 9C).
We next aligned the two sets of human T blast cell DHS data with
the ATAC data from Figs. 5B and 9D. This confirmed that many of
the ATAC peaks induced in Jurkat cells were also strongly induced
in primary T cells. This conclusion was further supported by 1)
aligning the Jurkat ATAC data with published histone H3K27Ac
chromatin immunoprecipitation sequencing data from stimulated
human CD4 T cells, showing the relative fold increase in signal in
response to stimulation, and 2) the average DHS profiles from the
above human T cell data for of the of 2795 inducible ATAC peaks
found in Jurkat T cells (Fig. 9D).
FIGURE 5. PMA and/or ionomycin treatments induce distinct chromatin changes. (A) Venn diagram showing differential chromatin regulation in Jurkat
T cells treated with PMA (20 ng/ml), ionomycin (1 mg/ml), or PMA and ionomycin (20 ng/ml PMA/1 mg/ml ionomycin) cotreatment. Shown are the
numbers of genes associated with ATAC-seq peaks that are upregulated by .2-fold by each condition relative to untreated cells. (B–D) Profiles of the
ATAC-seq signals within 2-kb windows centered on each peak for PMA/ionomycin (B), PMA (C), and ionomycin (D), aligned with the mRNA expression
levels (fold change relative to the untreated control) of the nearest gene (defined by the proximity between ATAC-seq peak and the nearest transcription start
site). Window-centered analysis includes the union of all peaks present in each treatment. Peaks are displayed in the order of increasing ATAC-seq signal
for each treatment relative to the untreated control. All Jurkat T cell ATAC peak data are available in Supplemental Table III, which lists the averages of
three independent ATAC values, and the fold change in response to specific stimuli.
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FIGURE 6. PMA/ionomycin-induced gene expression patterns are correlated with chromatin changes. (A) Comparison of individual inducible reponses
to the single and combined stimuli for each of the 455 genes upregulated (by 5-fold) by PMA/ionomycin cotreatment (as defined in Fig. 2B). Shown are
scatter plots of individual gene expression values across different treatment conditions. A line representing identical values is shown in red. (B) Differential
analysis of the 2795 ATAC-seq peaks that were induced by PMA and ionomycin cotreatment by 2-fold (as defined in Fig. 4A). Shown are scatter plots of
individual ATAC-seq peak values across different treatment conditions. Data are represented either as peak intensity or fold change (FC) in log2 scale. A
line representing identical values is shown in red. The broken line indicates the level of no fold change. (C) Distribution of ATAC-seq peak values across
different treatment conditions (in log2).
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Discussion
This study has confirmed the long-held view that integration of Ca2+
and kinase signaling is needed for efficient activation of induc-
ible gene expression in T cells. We found that for many immune
response genes, both signals are needed to open up the chromatin
and activate transcription. However, the immune system encom-
passes other genes that are induced in a range of cell types, by
a wide variety of other receptors linked to kinase but not Ca2+
signaling pathways. These include proinflammatory receptors,
such as Toll family receptors, and receptors that respond to cy-
tokines such as IL-1 and TNF, which also lead to induction of the
TFs AP-1 and NF-kB. For these reasons it makes sense that we
find a subset of genes that are induced by PMA via PKC-dependent
pathways, in the absence of Ca2+ signaling. Significantly, we found
that two-thirds of all of the genes induced 5-fold by TNF were also
induced 5-fold by PMA (Table I). In contrast, there appear to be
fewer gene-inducing signaling pathways linked to Ca2+ signaling in
the absence of kinase signaling.
Previous studies have also found that cooperation between NFAT
and AP-1 is required for efficient responses by most TCR-inducible
genes. T cells lose the ability to efficiently activate TCR-inducible
genes in cells expressing an engineered form of NFATc2, in which
the AP-1–binding domain is mutated (41, 42). This cooperation is
also dependent on the spatial relationship between the NFAT and
AP-1 complexes (24). An example of this type of composite el-
ement is seen in the sequence 59-GGGAAACACTGAGCAG-39 in
FIGURE 7. Differential regulation of the chromatin landscape. (A) Result of de novo TF binding motif search of PMA-specific (top), ionomycin-specific
(middle), or PMA/ionomycin-specific (bottom) ATAC-seq peaks using HOMER. Top motifs characterized by the fraction of peaks present (per treatment),
sequence logo, and p value for enrichment (versus randomized sequence control) are shown. (B) Profiles of the ATAC-seq signals within each 2-kb window
centered on each peak for PMA, ionomycin, and PMA/ionomycin aligned with the locations of the specific TF binding motifs. Window-centered analysis
includes the union of all peaks present in each treatment, with peaks displayed in order of increasing ATAC-seq signal for each treatment relative to the control.
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the GEM intronic enhancer in Fig. 4A, which has incomplete
versions of the underlined NFAT and AP-1 motifs. As with similar
elements in the CSF2 enhancer (25), this enhancer probably relies
on integration between calcium and kinase signaling because it is
predicted to bind NFAT and AP-1 in a highly cooperative manner.
It is also known that composite NFAT/AP-1 motifs that do not
have the binding sites orientated in the precise arrangement
depicted in Fig. 1B, such as the GM170 element in the CSF2
enhancer, are found to have much less transactivation potential
and fail to support cooperative binding of NFAT and AP-1 (25).
Furthermore, it has also been proposed that NFAT and AP-1 can
cooperate by supporting separate functions. A study of the GM420
high-affinity NFAT-binding site from the CSF2 enhancer revealed
that an array of three copies of just the NFAT site, without the
adjacent AP-1 motif, was sufficient to create an inducible DHS but
not sufficient to activate transcription of a linked reporter gene
(15). This specific NFAT site was able to function as a strong
activator of transcription only when it was linked to the AP-1
FIGURE 8. Digital genomic footprinting analyses (63) showing occupancy at genomic coordinates of AP-1, NFAT, and composite NFAT/AP-1 motifs
identified in 2-fold–induced ATAC peaks in untreated Jurkat cells and Jurkat cells stimulated with PMA plus ionomycin, PMA alone, or ionomycin alone.
Upper strand reads are shown in red and lower strand reads are shown in blue.
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motif. However, the CSF2 enhancer includes just one high-affinity
NFAT, with two of the NFAT sites relying on AP-1 for efficient
binding (25). In its natural context, the CSF2 enhancer also re-
quires cooperation between NFAT and AP-1 for efficient induction
of a DHS, whereby calcium ionophore alone is a poor inducer
(18). An analysis of TF occupancy also suggested that NFAT and
AP-1 are very inefficient at binding independently when induced
by either PMA or ionomycin alone (Fig. 8).
Our results also suggest that it is the synergistic action of in-
ducible TFs acting together, including NFAT, AP-1, NF-kB, and
EGR family proteins, that is responsible for opening up the
chromatin at TCR-inducible enhancers, as well as the tightly reg-
ulated inducible properties of these elements. In rare cases, such
as in the ZBTB16 locus, several copies of just an NFAT motif are
found, which are also sufficient to direct chromatin opening, as
described above for an artificial array of strong NFAT sites. As
observed in our previous study of activated mouse T cells (1), the
inducible DHSs defined in this study were also less enriched in
motifs for constitutive TFs, such as ETS and RUNX family pro-
teins. In contrast, these motifs are known to be enriched in DNA
elements that function as locus priming elements in previously
activated T cells, and which exist as constitutive DHSs in Jurkat
T cells (1, 69, 77). Similarly, RUNX and ETS motifs were found
at a higher density in the PMA-inducible and ionomycin-inducible
DHSs. This suggests that for many TCR-inducible DHSs, the
required critical mass of TFs is not attained using either PMA or
FIGURE 9. DHS analyses of human T cells stimulated with PMA and calcium ionophore. (A) DNase-seq profiles of actively dividing human T blast cells
before and after stimulation with PMA and A23187, ranked in order of increasing inducibility. (B) Results of de novo TF binding motif search for the 8171
DHS peaks induced 2-fold in human T blast cells determined using HOMER. (C) Venn diagram showing the overlap between 8171 DHS peaks induced
2-fold in human T blast cells compared with 2795 ATAC peaks induced 2-fold in Jurkat T cells. (D) Side-by-side comparison of profiles of DHS peaks
present in stimulated human T blast cells on the same axis alongside the Jurkat T cell ATAC peaks ranked as in Fig. 7B for Jurkat cells stimulated with
PMA and ionomycin. Also shown alongside are 1) the locations of inducible histone H3K27Ac regions as identified from published data from resting and
stimulated human CD4 T cells (66), and 2) the average profiles for the 2795 peaks defined as inducible in Jurkat cells in (D) using values from human
T blast cells before and after stimulation with PMA and A23187 as in (A).
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ionomycin alone, but can be attained when RUNX and ETS motifs
are present at a sufficient density. Although some DHSs were
observed to be strongly induced by just PMA or ionomycin alone
(e.g., ZBTB16, DUSP5, and EGR1, Fig. 3B), most of the PMA-
inducible mRNA changes were not associated with an inducible
DHS change (e.g., BIRC3, BCL3, RELB, and TNAIP3) However,
an examination of publicly available data (http://genome.cse.ucsc.
edu/) revealed that these genes do contain numerous constitutive
DHSs, which are present in Jurkat T cells but not in naive T cells
(data not shown). This implies that much of the PMA response in
Jurkat cells is mediated via constitutively open chromatin regions
that recruit PMA-inducible factors. These regions most likely
correspond to the priming elements previously defined in mouse
T cells, which are maintained by ETS and RUNX factors (1).
Overall, this study demonstrates that tight regulation of most
immune response genes is made possible by the obligate coop-
eration between Ca2+- and kinase-inducible factors acting at the
level of chromatin, whereas a small subset of genes exist in a
poised state able to respond to just a kinase signal.
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